For: | Rajkumar J, Sekar M, Mitra S. Safety and efficacy of oral HD-03/ES given for six months in patients with chronic hepatitis B virus infection. World J Gastroenterol 2007; 13(30): 4103-4107 [PMID: 17696230 DOI: 10.3748/wjg.v13.i30.4103] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v13/i30/4103.htm |
Number | Citing Articles |
1 |
Sandeep R. Varma, R. Sundaram, S. Gopumadhavan, Satyakumar Vidyashankar, Pralhad S. Patki. HD-03/ES: A Herbal Medicine Inhibits Hepatitis B Surface Antigen Secretion in Transfected Human Hepatocarcinoma PLC/PRF/5 Cells. Hepatitis Research and Treatment 2013; 2013: 1 doi: 10.1155/2013/125398
|
2 |
Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 2008; 17(4) doi: 10.1002/pds.1485
|
3 |
|
4 |
Haiyong Jia, Diwakar Rai, Peng Zhan, Xuwang Chen, Xuemei Jiang, Xinyong Liu. Recent Advance of the Hepatitis B Virus Inhibitors: A Medicinal Chemistry Overview. Future Medicinal Chemistry 2015; 7(5): 587 doi: 10.4155/fmc.15.19
|
5 |
Chetan Kantharia, Munesh Kumar, Mukesh Kumar Jain, Lokendra Sharma, Lokesh Jain, Anish Desai. Hepatoprotective Effects of Liv.52 in Chronic Liver Disease Preclinical, Clinical, and Safety Evidence: A Review. Gastroenterology Insights 2023; 14(3): 293 doi: 10.3390/gastroent14030021
|
6 |
Thanasekaran Jayakumar, Cheng-Ying Hsieh, Jie-Jen Lee, Joen-Rong Sheu. Experimental and Clinical Pharmacology ofAndrographis paniculataand Its Major Bioactive Phytoconstituent Andrographolide. Evidence-Based Complementary and Alternative Medicine 2013; 2013: 1 doi: 10.1155/2013/846740
|
7 |
Premashis Kar, Mohammad Asim, Manash Pratim Sarma, Pralhad S. Patki. HD-03/ES: A promising herbal drug for HBV antiviral therapy. Antiviral Research 2009; 84(3): 249 doi: 10.1016/j.antiviral.2009.09.013
|
8 |
Chandrashekaran Girish, Suresh Chandra Pradhan. Indian herbal medicines in the treatment of liver diseases: problems and promises. Fundamental & Clinical Pharmacology 2012; 26(2): 180 doi: 10.1111/j.1472-8206.2011.01011.x
|